AGILYSYS INC (AGYS) Fundamental Analysis & Valuation

NASDAQ:AGYS • US00847J1051

77.16 USD
-2.59 (-3.25%)
Last: Mar 6, 2026, 12:52 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This AGYS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

AGYS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 276 industry peers in the Software industry. While AGYS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. AGYS shows excellent growth, but is valued quite expensive already. These ratings could make AGYS a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. AGYS Profitability Analysis

1.1 Basic Checks

  • AGYS had positive earnings in the past year.
  • In the past year AGYS had a positive cash flow from operations.
  • AGYS had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years AGYS had a positive operating cash flow.
AGYS Yearly Net Income VS EBIT VS OCF VS FCFAGYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M

1.2 Ratios

  • The Return On Assets of AGYS (6.40%) is better than 76.45% of its industry peers.
  • AGYS has a Return On Equity of 9.72%. This is in the better half of the industry: AGYS outperforms 73.91% of its industry peers.
  • AGYS has a Return On Invested Capital of 7.91%. This is in the better half of the industry: AGYS outperforms 79.71% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for AGYS is below the industry average of 10.72%.
  • The last Return On Invested Capital (7.91%) for AGYS is above the 3 year average (7.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.4%
ROE 9.72%
ROIC 7.91%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
AGYS Yearly ROA, ROE, ROICAGYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • Looking at the Profit Margin, with a value of 9.79%, AGYS is in the better half of the industry, outperforming 73.19% of the companies in the same industry.
  • In the last couple of years the Profit Margin of AGYS has grown nicely.
  • AGYS has a Operating Margin of 9.71%. This is in the better half of the industry: AGYS outperforms 76.09% of its industry peers.
  • In the last couple of years the Operating Margin of AGYS has grown nicely.
  • AGYS has a Gross Margin of 61.67%. This is in the lower half of the industry: AGYS underperforms 60.51% of its industry peers.
  • In the last couple of years the Gross Margin of AGYS has grown nicely.
Industry RankSector Rank
OM 9.71%
PM (TTM) 9.79%
GM 61.67%
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
AGYS Yearly Profit, Operating, Gross MarginsAGYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. AGYS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AGYS is destroying value.
  • AGYS has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for AGYS has been increased compared to 5 years ago.
  • Compared to 1 year ago, AGYS has a worse debt to assets ratio.
AGYS Yearly Shares OutstandingAGYS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AGYS Yearly Total Debt VS Total AssetsAGYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • AGYS has an Altman-Z score of 9.82. This indicates that AGYS is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 9.82, AGYS belongs to the best of the industry, outperforming 90.94% of the companies in the same industry.
  • AGYS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.82
ROIC/WACC0.71
WACC11.08%
AGYS Yearly LT Debt VS Equity VS FCFAGYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • AGYS has a Current Ratio of 1.31. This is a normal value and indicates that AGYS is financially healthy and should not expect problems in meeting its short term obligations.
  • AGYS's Current ratio of 1.31 is on the low side compared to the rest of the industry. AGYS is outperformed by 60.51% of its industry peers.
  • A Quick Ratio of 1.25 indicates that AGYS should not have too much problems paying its short term obligations.
  • AGYS has a Quick ratio of 1.25. This is in the lower half of the industry: AGYS underperforms 63.04% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.25
AGYS Yearly Current Assets VS Current LiabilitesAGYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. AGYS Growth Analysis

3.1 Past

  • AGYS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.12%, which is quite impressive.
  • Measured over the past years, AGYS shows a very strong growth in Earnings Per Share. The EPS has been growing by 47.96% on average per year.
  • AGYS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.86%.
  • The Revenue has been growing by 11.38% on average over the past years. This is quite good.
EPS 1Y (TTM)26.12%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10.53%
Revenue 1Y (TTM)17.86%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%15.57%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.38% on average over the next years. This is a very strong growth
  • AGYS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.76% yearly.
EPS Next Y6.32%
EPS Next 2Y18.73%
EPS Next 3Y21.38%
EPS Next 5YN/A
Revenue Next Year16.54%
Revenue Next 2Y15.44%
Revenue Next 3Y15.02%
Revenue Next 5Y21.76%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AGYS Yearly Revenue VS EstimatesAGYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
AGYS Yearly EPS VS EstimatesAGYS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

2

4. AGYS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 45.66, AGYS can be considered very expensive at the moment.
  • AGYS's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of AGYS to the average of the S&P500 Index (26.69), we can say AGYS is valued expensively.
  • With a Price/Forward Earnings ratio of 35.09, AGYS can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AGYS is on the same level as its industry peers.
  • AGYS is valuated rather expensively when we compare the Price/Forward Earnings ratio to 24.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 45.66
Fwd PE 35.09
AGYS Price Earnings VS Forward Price EarningsAGYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as AGYS.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of AGYS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 36.64
EV/EBITDA 53.53
AGYS Per share dataAGYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of AGYS may justify a higher PE ratio.
  • AGYS's earnings are expected to grow with 21.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.23
PEG (5Y)0.95
EPS Next 2Y18.73%
EPS Next 3Y21.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AGYS Dividend Analysis

5.1 Amount

  • No dividends for AGYS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AGYS Fundamentals: All Metrics, Ratios and Statistics

AGILYSYS INC

NASDAQ:AGYS (3/6/2026, 12:52:33 PM)

77.16

-2.59 (-3.25%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-26
Earnings (Next)05-18
Inst Owners106.42%
Inst Owner Change-0.61%
Ins Owners4.27%
Ins Owner Change-0.22%
Market Cap2.17B
Revenue(TTM)310.64M
Net Income(TTM)30.42M
Analysts81.43
Price Target139.11 (80.29%)
Short Float %6.34%
Short Ratio5.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.76%
Min EPS beat(2)-9.64%
Max EPS beat(2)2.12%
EPS beat(4)2
Avg EPS beat(4)16.71%
Min EPS beat(4)-10.75%
Max EPS beat(4)85.11%
EPS beat(8)6
Avg EPS beat(8)14.3%
EPS beat(12)10
Avg EPS beat(12)18.27%
EPS beat(16)14
Avg EPS beat(16)20.42%
Revenue beat(2)1
Avg Revenue beat(2)0.44%
Min Revenue beat(2)-0.27%
Max Revenue beat(2)1.14%
Revenue beat(4)3
Avg Revenue beat(4)0.98%
Min Revenue beat(4)-0.27%
Max Revenue beat(4)1.95%
Revenue beat(8)3
Avg Revenue beat(8)-1.08%
Revenue beat(12)4
Avg Revenue beat(12)-0.78%
Revenue beat(16)8
Avg Revenue beat(16)0.02%
PT rev (1m)-2.39%
PT rev (3m)-1.21%
EPS NQ rev (1m)3.27%
EPS NQ rev (3m)4.69%
EPS NY rev (1m)-2.55%
EPS NY rev (3m)-2.15%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.97%
Valuation
Industry RankSector Rank
PE 45.66
Fwd PE 35.09
P/S 6.98
P/FCF 36.64
P/OCF 35.37
P/B 6.93
P/tB 19.99
EV/EBITDA 53.53
EPS(TTM)1.69
EY2.19%
EPS(NY)2.2
Fwd EY2.85%
FCF(TTM)2.11
FCFY2.73%
OCF(TTM)2.18
OCFY2.83%
SpS11.05
BVpS11.14
TBVpS3.86
PEG (NY)7.23
PEG (5Y)0.95
Graham Number20.58
Profitability
Industry RankSector Rank
ROA 6.4%
ROE 9.72%
ROCE 8.73%
ROIC 7.91%
ROICexc 10.35%
ROICexgc 46.15%
OM 9.71%
PM (TTM) 9.79%
GM 61.67%
FCFM 19.05%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
ROICexc(3y)15.95%
ROICexc(5y)N/A
ROICexgc(3y)439.05%
ROICexgc(5y)N/A
ROCE(3y)7.91%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-16.81%
ROICexc growth 5YN/A
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 20.82%
Cap/Sales 0.68%
Interest Coverage 250
Cash Conversion 151.93%
Profit Quality 194.56%
Current Ratio 1.31
Quick Ratio 1.25
Altman-Z 9.82
F-Score7
WACC11.08%
ROIC/WACC0.71
Cap/Depr(3y)131.65%
Cap/Depr(5y)90.98%
Cap/Sales(3y)2.69%
Cap/Sales(5y)1.97%
Profit Quality(3y)162.49%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.12%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10.53%
EPS Next Y6.32%
EPS Next 2Y18.73%
EPS Next 3Y21.38%
EPS Next 5YN/A
Revenue 1Y (TTM)17.86%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%15.57%
Revenue Next Year16.54%
Revenue Next 2Y15.44%
Revenue Next 3Y15.02%
Revenue Next 5Y21.76%
EBIT growth 1Y16.97%
EBIT growth 3Y46.64%
EBIT growth 5YN/A
EBIT Next Year197.99%
EBIT Next 3Y68.08%
EBIT Next 5Y56.79%
FCF growth 1Y147.44%
FCF growth 3Y24.23%
FCF growth 5Y48.7%
OCF growth 1Y74.29%
OCF growth 3Y24.6%
OCF growth 5Y39.06%

AGILYSYS INC / AGYS FAQ

Can you provide the ChartMill fundamental rating for AGILYSYS INC?

ChartMill assigns a fundamental rating of 6 / 10 to AGYS.


What is the valuation status for AGYS stock?

ChartMill assigns a valuation rating of 2 / 10 to AGILYSYS INC (AGYS). This can be considered as Overvalued.


Can you provide the profitability details for AGILYSYS INC?

AGILYSYS INC (AGYS) has a profitability rating of 7 / 10.


How financially healthy is AGILYSYS INC?

The financial health rating of AGILYSYS INC (AGYS) is 6 / 10.


Can you provide the expected EPS growth for AGYS stock?

The Earnings per Share (EPS) of AGILYSYS INC (AGYS) is expected to grow by 6.32% in the next year.